Complete remission with bortezomib on plasmocytomas in an end-stage patient with refractory multiple myeloma who failed all other therapies including hematopoietic stem cell transplantation: possible enhancement of graft-vs-tumor effect

Leukemia. 2005 Sep;19(9):1702-4. doi: 10.1038/sj.leu.2403855.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Boronic Acids / therapeutic use*
  • Bortezomib
  • Follow-Up Studies
  • Graft vs Leukemia Effect*
  • Hematopoietic Stem Cell Transplantation*
  • Humans
  • Male
  • Middle Aged
  • Multiple Myeloma / complications
  • Multiple Myeloma / drug therapy*
  • Plasmacytoma / complications
  • Plasmacytoma / drug therapy*
  • Pyrazines / therapeutic use*
  • Remission Induction
  • Tomography, X-Ray Computed
  • Treatment Failure
  • Treatment Outcome

Substances

  • Boronic Acids
  • Pyrazines
  • Bortezomib